Novartis Investigative Site

Panama City, Florida 32405

0 studies enrolling now · 2 studies all time

What they study most

Chronic Obstructive Pulmonary Disease, Multiple Sclerosis

Studies at this site

• Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies — Completed
• 1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD) — Completed